IDH2 and brain cancer: Factors predicting better prognosis in patients with brain cancer, such as IDH mutations and 1p/19q codeletion, were often lost in the grade II/III primary cells, whereas those that predicted poor outcome, such as chromosome 7p gain and10q loss, were preserved in the GBM primary cells.